How can India address concerns about access to affordable medicines while negotiating Free Trade Agreements (FTAs)?
Médecins Sans Frontières has raised concerns that FTAs may restrict access to medicines in India and other developing countries. I want to understand the policy options available to India to protect public health interests during trade negotiations.